Showing results (1-10 of 96) with videos related to
Sort By:
Pageof 10
Endocrine-Related Cancer|September 17, 2004
Telomerase as a new target for the treatment of hormone-refractory prostate cancerAnnamaria Biroccio, Carlo LeonettiMethods (San Diego, Calif.)|March 14, 2012
Methods of studying telomere damage induced by quadruplex-ligand complexesAngela Rizzo, Erica Salvati, Annamaria BiroccioOncogene|October 7, 2003
The future of antisense therapy: combination with anticancer treatmentsAnnamaria Biroccio, Carlo Leonetti, Gabriella ZupiMolecular Pharmacology|July 14, 2007
Gamma-glutamylcysteine synthetase mediates the c-Myc-dependent response to antineoplastic agents in melanoma cellsBarbara Benassi, Gabriella Zupi, Annamaria BiroccioJournal of Experimental & Clinical Cancer Research : CR|January 19, 2019
Emerging roles of telomeric chromatin alterations in cancerStefano Cacchione, Annamaria Biroccio, Angela RizzoPharmaceuticals (Basel, Switzerland)|June 27, 2024
Therapeutic Use of G4-Ligands in Cancer: State-of-the-Art and Future PerspectivesSara Iachettini, Annamaria Biroccio, Pasquale ZizzaJournal of Experimental & Clinical Cancer Research : CR|December 24, 2017
Diagnosis and treatment of ALT tumors: is Trabectedin a new therapeutic option?Luca Pompili, Carlo Leonetti, Annamaria Biroccio, et al.Neoplasia (New York, N.Y.)|May 22, 2004
Glutathione depletion induced by c-Myc downregulation triggers apoptosis on treatment with alkylating agentsAnnamaria Biroccio, Barbara Benassi, Francesco Fiorentino, et al.Oncoimmunology|April 5, 2014
A novel pathway links telomeres to NK-cell activity: Implications for immunotherapyJulien Cherfils-Vicini, Pasquale Zizza, Eric Gilson, et al.Biochimica Et Biophysica Acta. General Subjects|November 14, 2016
EMICORON: A multi-targeting G4 ligand with a promising preclinical profileManuela Porru, Pasquale Zizza, Marco Franceschin, et al.Pageof 10